Search Results 121-130 of 20564 for colitis

1. Publications - Talha A. Malik, M.D. - Mayo Clinic

   Acute Severe Ulcerative Colitis (ASUC): Clinical Features, Initial Management, and the Role of Advanced Therapies. Biomedicines. 2025 Oct 18; 13(10). View ...

2. Lifestyle and Diet in Inflammatory Bowel Disease - Mayo Clinic News Network

   Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...

3. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

   ... Colitis (UC) within the Pediatric Population. Print details. Share; Facebook ... colitis (UC) within the ICN network. This will be a retrospective ...

4. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

   ... colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

5. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   The purpose of this study is to assess the effectiveness and safety of BMS-986165 in ulcerative colitis. Participation eligibility. Participant eligibility ...

6. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

7. Gui Piovezani Ramos, M.D. - Doctors and Medical Staff - Mayo Clinic

   Complex Crohn's Disease and Ulcerative Colitis · Checkpoint-inhibitor colitis / enterocolitis · Mucosal Immunology · Personalized Medicine in IBD ...

8. A Study of the Safety and Effectiveness of GS-5745 in Adults with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Participation eligibility · Ulcerative Colitis (UC) confirmed on endoscopy · Moderately to severely active UC (Mayo Score 6-12) · May be receiving. Oral 5- ...

9. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

   Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).

10. Mayo Clinic Q and A: Treating inflammatory bowel disease

    It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...